Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

Long-term finasteride use may lower prostate cancer risk but increase the need for erectile dysfunction medication.

The Princeton III Consensus recommends assessing cardiovascular risk in men with erectile dysfunction and prioritizing heart health before treating ED, especially in those with potential heart disease.

Finasteride and SSRIs together increase impotence and low libido risk in men.

The new microneedle treatment could be a more effective and convenient option for hair loss.

The document summarized how various modern drugs are made.

Persistent ED in Propecia users is not due to abnormal blood flow.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

DPP may help hair regrowth by improving blood vessel function under stress.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

PRP injections are safe but don't significantly improve Peyronie's Disease.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Finasteride increases CD8+ T cells in BPH tissues.

5-alpha-reductase inhibitors significantly affect the penile tissue of hypertensive rats.

SHH protein helps nerve regeneration in hypertensive rats.

Regulatory challenges make developing combination therapies in urology difficult and costly.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.